Putu Duff1, Shira Goldenberg, Kathleen Deering, Julio Montaner, Paul Nguyen, Sabina Dobrer, Kate Shannon. 1. *British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC, Canada;†Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, BC, Canada; and‡Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
Abstract
OBJECTIVE: Despite global evidence that sex workers (SWs) are disproportionately impacted by HIV, data on HIV treatment outcomes among SWs living with HIV remains sparse. This study examined the correlates of undetectable plasma viral load (pVL) among street- and off-street SWs living with HIV and on antiretroviral therapy (ART) in Metro Vancouver, Canada. METHODS: Analyses drew on data (2010-2014) from a longitudinal cohort of SWs (An Evaluation of Sex Workers Health Access) and confidential linkages with the Drug Treatment Program (DTP) data on ART dispensation and outcomes. Bivariate and multivariable generalized linear mixed-effects models were used to identify longitudinal correlates of undetectable pVL (<50 copies/mL). RESULTS: Of the 72 SWs living with HIV who had ever used ART, 38.9% had an undetectable pVL at baseline. Although 84.7% had undetectable pVL at least once over the study period, 18.1% exhibited sustained undetectable pVL. In multivariable generalized linear mixed-effects model analyses, ≥95% pharmacy refill adherence (adjusted odds ratio (AOR) = 4.21; 95% confidence interval (CI) 2.16 to 8.19) and length of time since diagnosis (AOR = 1.06; 95% CI: 1.00 to 1.13) were positively correlated with undetectable pVL. Having an intimate male partner (AOR = 0.35; 95% CI: 0.16 to 0.78) and being homelessness were negatively correlated with undetectable pVL (AOR = 0.22; 95% CI: 0.10 to 0.47). DISCUSSION/ CONCLUSIONS: There is a need to more closely consider the social and structural contexts that shape SWs' experiences on ART and impact treatment outcomes, including the gendered power dynamics within intimate partnerships. Future research on HIV care among SWs is urgently needed, alongside structural and community-led interventions to support SWs' access to and retention in care.
OBJECTIVE: Despite global evidence that sex workers (SWs) are disproportionately impacted by HIV, data on HIV treatment outcomes among SWs living with HIV remains sparse. This study examined the correlates of undetectable plasma viral load (pVL) among street- and off-street SWs living with HIV and on antiretroviral therapy (ART) in Metro Vancouver, Canada. METHODS: Analyses drew on data (2010-2014) from a longitudinal cohort of SWs (An Evaluation of Sex Workers Health Access) and confidential linkages with the Drug Treatment Program (DTP) data on ART dispensation and outcomes. Bivariate and multivariable generalized linear mixed-effects models were used to identify longitudinal correlates of undetectable pVL (<50 copies/mL). RESULTS: Of the 72 SWs living with HIV who had ever used ART, 38.9% had an undetectable pVL at baseline. Although 84.7% had undetectable pVL at least once over the study period, 18.1% exhibited sustained undetectable pVL. In multivariable generalized linear mixed-effects model analyses, ≥95% pharmacy refill adherence (adjusted odds ratio (AOR) = 4.21; 95% confidence interval (CI) 2.16 to 8.19) and length of time since diagnosis (AOR = 1.06; 95% CI: 1.00 to 1.13) were positively correlated with undetectable pVL. Having an intimate male partner (AOR = 0.35; 95% CI: 0.16 to 0.78) and being homelessness were negatively correlated with undetectable pVL (AOR = 0.22; 95% CI: 0.10 to 0.47). DISCUSSION/ CONCLUSIONS: There is a need to more closely consider the social and structural contexts that shape SWs' experiences on ART and impact treatment outcomes, including the gendered power dynamics within intimate partnerships. Future research on HIV care among SWs is urgently needed, alongside structural and community-led interventions to support SWs' access to and retention in care.
Authors: T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray Journal: N Engl J Med Date: 2000-03-30 Impact factor: 91.245
Authors: Sabra S Inslicht; Charles R Marmar; Thomas C Neylan; Thomas J Metzler; Stacey L Hart; Christian Otte; Shannon E McCaslin; G Luke Larkin; Kelly B Hyman; Andrew Baum Journal: Psychoneuroendocrinology Date: 2006-05-23 Impact factor: 4.905
Authors: Viviane D Lima; Josie Geller; David R Bangsberg; Thomas L Patterson; Mark Daniel; Thomas Kerr; Julio S G Montaner; Robert S Hogg Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Putu K Duff; Deborah M Money; Gina S Ogilvie; Florence Ranville; Mary Kestler; Melissa C Braschel; Neora Pick; Kate Shannon Journal: Menopause Date: 2018-05 Impact factor: 2.953
Authors: Jennifer L Glick; Rienna Russo; Belinda Jivapong; Lori Rosman; Danielle Pelaez; Katherine H A Footer; Susan G Sherman Journal: AIDS Behav Date: 2020-05
Authors: Jennifer L Glick; Rienna G Russo; Aimee Kao-Hsuan Huang; Belinda Jivapong; Vijayasundaram Ramasamy; Lori M Rosman; Danielle L Pelaez; Susan G Sherman Journal: Glob Public Health Date: 2020-12-10
Authors: Gertrude Namale; Onesmus Kamacooko; Daniel Bagiire; Yunia Mayanja; Andrew Abaasa; William Kilembe; Matt Price; Deogratius Ssemwanga; Sandra Lunkuse; Maria Nanyonjo; William Ssenyonga; Philippe Mayaud; Rob Newton; Pontiano Kaleebu; Janet Seeley Journal: Sex Transm Infect Date: 2019-07-02 Impact factor: 3.519
Authors: Catherine E Oldenburg; Katrina F Ortblad; Michael M Chanda; Magdalene Mwale; Steven Chongo; Catherine Kanchele; Nyambe Kamungoma; Andrew Fullem; Till Bärnighausen Journal: J Acquir Immune Defic Syndr Date: 2018-12-01 Impact factor: 3.731